Disclosures

Notification by Win Medica of benefits under the provisions of Article 66 par. 7a of Law 4316/2014, the Disclosure Code of the SFEI and the Disclosure Code of EFPIA.

Choose to view any disclosure you wish.

Disclosure 2015

Notification by Win Medica of benefits under the provisions of Article 66 para. 7a of Law 4316/2014, the Disclosure Code of the SFEE and the Disclosure Code of EFPIA.

According to Article 66 par. 7a of Law 4316/2014, pharmaceutical companies in Greece are required to disclose, in accordance with the above provisions, on an individual basis per recipient each benefit they provide to Health Care Professionals (HCPs) and Scientific Health Care Providers (SHPs). In addition, the Disclosure Code of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Disclosure Code of the Hellenic Federation of Pharmaceutical Industries and Associations (SFEE) require their members to disclose payments and benefits to Healthcare Professionals (HCPs) and Scientific Healthcare Providers (HCBs).

On this page, the benefits of Win Medica to Healthcare Professionals (HCPs) and individually the corresponding benefits to Scientific Healthcare Providers (SSPs) for the period from 01/01/2015 – 31/12/2015 are published in an aggregated manner.

We expressly note that this disclosure was formulated after the issuance of Opinion No. 5/2016 of the Data Protection Authority, the content of which we only became aware of today 30.6.2016. We reserve the right to an updated disclosure pending the final instructions of the administration’s stakeholders.

In any case, this disclosure is intended to enhance transparency in the relations between pharmaceutical companies and the EHR and the EIF and to defend the right of patients to know the relationship between pharmaceutical companies and the scientific community.

You can download Win Medica S.A.’s 2015 disclosure from here.

Disclosure 2016

Legal basis of the disclosure: Law 4316 [Government Gazette 270A / 24.12.2014, Article 66, par. 7 (a)], “every Pharmaceutical Company must publish by name on its website and on the special website of EOF, no later than six months from the closing of each calendar year, any benefit granted to third parties Health Professionals and Scientific Health Institutions …… .. regarding the promotion of prescription drugs».

Purpose of disclosure: transparency and consolidation of trust in pharmaceutical companies’ relationships with patients, healthcare professionals, scientific healthcare providers and society.

Taking into account the local Legislation (law 4316/2014), the nos. 5/2016 and 2/2017 Opinions of the Personal Data Protection Authority, the Code of Conduct of SFEE, Win Medica publishes the values transferred to EY and EYF, which relate to the commercial distribution of prescription drugs for human use as follows.

  • Aggregate: the values ​​transferred to Health Professionals (HE) for their participation in Type A Events inside and outside (registration, accommodation, transfer costs), fees for the provision of consulting or other services (eg advisory boards, training, etc.) as well as the benefits which Win Medica has done in terms of Research and Development.
  • Nominal / individual: the values ​​transferred to Scientific Health Institutions (EYF) as well as to EY for their participation in events of Type B-Promotional character in detail and distinctly by category of provision (ie travel expenses, accommodation expenses, etc.).
    The time of posting the data on the internet is three years.

In each expense shown in the Table, it is indicated whether the amounts relate to gross or net fees. The recorded amounts refer to amounts paid by Win Medica to EY and EYF within 2016 (regardless of the interval related to the provision of service).

Responsible: Win Medica Pharmaceutical Societe Anonyme, Oedipus 1-3 & Paradromos Attiki Odos 33-35, 152 38 Chalandri Attica, Tel. 210-7488821, Fax: 210-7488827, email: info@winmedica.gr

Health professionals who are the subjects of the published data are reminded that they have the right to access and correct any inaccurate data. The relevant requests must be submitted in writing by sending a letter or email to the above addresses and must contain a request for a specific action.

You can download the disclosure of Win Medica A.E. for 2016 from here

Disclosure 2017

Legal basis of the disclosure: Law 4316 [Government Gazette 270A / 24.12.2014, Article 66, par. 7 (a)], “every Pharmaceutical Company must publish by name on its website and on the special website of EOF, no later than six months from the closing of each calendar year, any benefit granted to third parties Health Professionals and Scientific Health Institutions …… .. regarding the promotion of prescription drugs».

Purpose of disclosure: transparency and consolidation of trust in pharmaceutical companies’ relationships with patients, healthcare professionals, scientific healthcare providers and society.

Taking into account the local Legislation (law 4316/2014), the nos. 5/2016 and 2/2017 Opinions of the Personal Data Protection Authority, the Code of Conduct of SFEE, Win Medica publishes the values transferred to EY and EYF, which relate to the commercial distribution of prescription drugs for human use as follows.

  • Aggregate: the values ​​transferred to Health Professionals (HE) for their participation in Type A Events inside and outside (registration, accommodation, transfer costs), fees for the provision of consulting or other services (eg advisory boards, training, etc.) as well as the benefits which Win Medica has done in terms of Research and Development.
  • Nominal / individual: the values ​​transferred to Scientific Health Institutions (EYF) as well as to EY for their participation in events of Type B-Promotional character in detail and distinctly by category of provision (ie travel expenses, accommodation expenses, etc.).
    The time of posting the data on the internet is three years.

In each expense shown in the Table, it is indicated whether the amounts relate to gross or net fees. The recorded amounts refer to amounts paid by Win Medica to EY and EYF within 2016 (regardless of the interval related to the provision of service).

Responsible: Win Medica Pharmaceutical Societe Anonyme, Oedipus 1-3 & Paradromos Attiki Odos 33-35, 152 38 Chalandri Attica, Tel. 210-7488821, Fax: 210-7488827, email: info@winmedica.gr

Health professionals who are the subjects of the published data are reminded that they have the right to access and correct any inaccurate data. The relevant requests must be submitted in writing by sending a letter or email to the above addresses and must contain a request for a specific action.

You can download the disclosure of Win Medica A.E. for 2017 from here

Disclosure 2018

Legal basis of the disclosure: Law 4316 [Government Gazette 270A / 24.12.2014, Article 66, par. 7 (a)], “every Pharmaceutical Company must publish by name on its website and on the special website of EOF, no later than six months from the closing of each calendar year, any benefit granted to third parties Health Professionals and Scientific Health Institutions …… .. regarding the promotion of prescription drugs».

Purpose of disclosure: transparency and consolidation of trust in pharmaceutical companies’ relationships with patients, healthcare professionals, scientific healthcare providers and society.

Taking into account the local Legislation (law 4316/2014), the nos. 5/2016 and 2/2017 Opinions of the Personal Data Protection Authority, the Code of Conduct of SFEE, Win Medica publishes the values transferred to EY and EYF, which relate to the commercial distribution of prescription drugs for human use as follows.

  • Aggregate: the values ​​transferred to Health Professionals (HE) for their participation in Type A Events inside and outside (registration, accommodation, transfer costs), fees for the provision of consulting or other services (eg advisory boards, training, etc.) as well as the benefits which Win Medica has done in terms of Research and Development.
  • Nominal / individual: the values ​​transferred to Scientific Health Institutions (EYF) as well as to EY for their participation in events of Type B-Promotional character in detail and distinctly by category of provision (ie travel expenses, accommodation expenses, etc.).
    The time of posting the data on the internet is three years.

In each expense shown in the Table, it is indicated whether the amounts relate to gross or net fees. The recorded amounts refer to amounts paid by Win Medica to EY and EYF within 2016 (regardless of the interval related to the provision of service).

Responsible: Win Medica Pharmaceutical Societe Anonyme, Oedipus 1-3 & Paradromos Attiki Odos 33-35, 152 38 Chalandri Attica, Tel. 210-7488821, Fax: 210-7488827, email: info@winmedica.gr

Health professionals who are the subjects of the published data are reminded that they have the right to access and correct any inaccurate data. The relevant requests must be submitted in writing by sending a letter or email to the above addresses and must contain a request for a specific action.

You can download the disclosure of Win Medica A.E. for 2018 from here

Disclosure 2019

Legal basis of the disclosure: Law 4316 [Government Gazette 270A / 24.12.2014, Article 66, par. 7 (a)], “every Pharmaceutical Company must publish by name on its website and on the special website of EOF, no later than six months from the closing of each calendar year, any benefit granted to third parties Health Professionals and Scientific Health Institutions …… .. regarding the promotion of prescription drugs».

Purpose of disclosure: transparency and consolidation of trust in pharmaceutical companies’ relationships with patients, healthcare professionals, scientific healthcare providers and society.

Taking into account the local Legislation (law 4316/2014), the nos. 5/2016 and 2/2017 Opinions of the Personal Data Protection Authority, the Code of Conduct of SFEE, Win Medica publishes the values transferred to EY and EYF, which relate to the commercial distribution of prescription drugs for human use as follows.:

  • Aggregate: the values ​​transferred to Health Professionals (HE) for their participation in Type A Events inside and outside (registration, accommodation, transfer costs), fees for the provision of consulting or other services (eg advisory boards, training, etc.) as well as the benefits which Win Medica has done in terms of Research and Development.
  • Nominal/individual: the values ​​transferred to Scientific Health Institutions (EYF) as well as to EY for their participation in events of Type B-Promotional character in detail and distinctly by category of provision (ie travel expenses, accommodation expenses, etc.).
    The time of posting the data on the internet is three years.

In each expense shown in the Table, it is indicated whether the amounts relate to gross or net fees. The recorded amounts refer to amounts paid by Win Medica to EY and EYF within 2016 (regardless of the interval related to the provision of service).

According to Article 6 of the General Data Protection Regulation (EU) 2016/679 (GDPR), in order for a processing to be lawful, it is sufficient that it is necessary for the Compliance Officer to comply with a legal obligation.

Win Medica is responsible for processing the personal data of the EVs with which it cooperates. Based on the above, there is no obligation on the part of Win Medica to obtain the prior consent of the EVs for the disclosure of benefits provided by the latter, to the extent that such disclosure is a legal obligation of the company as the controller. It is noted that data subjects have the right to access and correct their personal data, the right to object, the right to be forgotten as well as the right to portability, to the extent that these rights are not restricted by the fulfillment of the above legal obligation of Win Medica, pursuant to Law 4316/2014.

Win Medica has made every effort to ensure that the attached disclosure report is in full compliance with the applicable legal and regulatory framework. Our goal is to maintain the maximum possible accuracy and completeness in the published data.

Responsible: Win Medica Pharmaceutical Societe Anonyme, Oedipus 1-3 & Paradromos Attiki Odos 33-35, 152 38 Chalandri Attica, Tel. 210-7488821, Fax: 210-7488827, email: info@winmedica.gr

Health professionals who are the subjects of the published data are reminded that they have the right to access and correct any inaccurate data. The relevant requests must be submitted in writing by sending a letter or email to the above addresses and must contain a request for a specific action.

You can download the disclosure of Win Medica S.A. for 2019 from here.

Disclosure 2020

Legal basis of the disclosure: Law 4316 [Government Gazette 270A / 24.12.2014, Article 66, par. 7 (a)], “every Pharmaceutical Company must publish by name on its website and on the special website of EOF, no later than six months from the closing of each calendar year, any benefit granted to third parties Health Professionals and Scientific Health Institutions …… .. regarding the promotion of prescription drugs».

Purpose of disclosure: transparency and consolidation of trust in pharmaceutical companies’ relationships with patients, healthcare professionals, scientific healthcare providers and society.

Taking into account the local Legislation (law 4316/2014), the nos. 5/2016 and 2/2017 Opinions of the Personal Data Protection Authority, the Code of Conduct of SFEE, Win Medica publishes the values transferred to EY and EYF, which relate to the commercial distribution of prescription drugs for human use as follows.:

  • Aggregate: the values ​​transferred to Health Professionals (HE) for their participation in Type A Events inside and outside (registration, accommodation, transfer costs), fees for the provision of consulting or other services (eg advisory boards, training, etc.) as well as the benefits which Win Medica has done in terms of Research and Development.
  • Nominal/individual: the values ​​transferred to Scientific Health Institutions (EYF) as well as to EY for their participation in events of Type B-Promotional character in detail and distinctly by category of provision (ie travel expenses, accommodation expenses, etc.).
    The time of posting the data on the internet is three years.

In each expense shown in the Table, it is indicated whether the amounts relate to gross or net fees. The recorded amounts refer to amounts paid by Win Medica to EY and EYF within 2020 (regardless of the interval related to the provision of service).

According to Article 6 of the General Data Protection Regulation (EU) 2016/679 (GDPR), in order for a processing to be lawful, it is sufficient that it is necessary for the Compliance Officer to comply with a legal obligation.

Win Medica is responsible for processing the personal data of the EVs with which it cooperates. Based on the above, there is no obligation on the part of Win Medica to obtain the prior consent of the EVs for the disclosure of benefits provided by the latter, to the extent that such disclosure is a legal obligation of the company as the controller. It is noted that data subjects have the right to access and correct their personal data, the right to object, the right to be forgotten as well as the right to portability, to the extent that these rights are not restricted by the fulfillment of the above legal obligation of Win Medica, pursuant to Law 4316/2014.

Win Medica has made every effort to ensure that the attached disclosure report is in full compliance with the applicable legal and regulatory framework. Our goal is to maintain the maximum possible accuracy and completeness in the published data.

Responsible: Win Medica Pharmaceutical Societe Anonyme, Oedipus 1-3 & Paradromos Attiki Odos 33-35, 152 38 Chalandri Attica, Tel. 210-7488821, Fax: 210-7488827, email: info@winmedica.gr

Health professionals who are the subjects of the published data are reminded that they have the right to access and correct any inaccurate data. The relevant requests must be submitted in writing by sending a letter or email to the above addresses and must contain a request for a specific action.

You can download the disclosure of Win Medica S.A. for 2020 from here.